Yield10 Bioscience Reports Preliminary 2016 Camelina Field Test Results Showing that the C3003 Trait Produces Significant Improvements in Seed Yield
January 26, 2017 16:05 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 26, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today announced preliminary field test results in its model Camelina system showing that the novel yield trait...
Yield10 Bioscience to Host Investor Conference Call
January 24, 2017 16:05 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 24, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that the Company will host a conference call and live webcast on Thursday, January 26th...
Metabolix Announces Third Quarter 2016 Financial Results
November 09, 2016 16:05 ET
|
Metabolix
CAMBRIDGE, Mass., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX), today reported financial results for the three months ended September 30, 2016. “We are excited to be moving...
Dr. Kristi Snell Representing Yield10 at Policy Event Focused on Building a 21st Century Agricultural Workforce
October 06, 2016 11:32 ET
|
Metabolix
WOBURN, Mass., Oct. 06, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX), today announced that Kristi Snell, Ph.D. is representing Yield10 Bioscience today at a policy event focused on...
Metabolix Announces $10 Million Binding Letter of Intent for Sale of Biopolymer Assets to CJ CheilJedang
August 22, 2016 16:05 ET
|
Metabolix
WOBURN, Mass., Aug. 22, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX) announced today that it has entered into a binding letter of intent (“LOI”) with CJ CheilJedang Corporation (“CJ”)...